Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.
Paredes R, Lalama CM, Ribaudo HJ, Schackman BR, Shikuma C, Giguel F, Meyer WA 3rd, Johnson VA, Fiscus SA, D'Aquila RT, Gulick RM, Kuritzkes DR; AIDS Clinical Trials Group (ACTG) A5095 Study Team.
Paredes R, et al. Among authors: giguel f.
J Infect Dis. 2010 Mar;201(5):662-71. doi: 10.1086/650543.
J Infect Dis. 2010.
PMID: 20102271
Free PMC article.